These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 17690897)
1. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Chung EJ; Kim JH; Ahn HS; Koh HJ Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897 [TBL] [Abstract][Full Text] [Related]
2. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results]. Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695 [TBL] [Abstract][Full Text] [Related]
3. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Kim J; Kim SJ; Chang YS; Park WS Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184 [TBL] [Abstract][Full Text] [Related]
4. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels. Lee JY; Chae JB; Yang SJ; Yoon YH; Kim JG Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1257-62. PubMed ID: 20393741 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Nazari H; Modarres M; Parvaresh MM; Ghasemi Falavarjani K Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1713-8. PubMed ID: 20582706 [TBL] [Abstract][Full Text] [Related]
6. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis. Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024 [TBL] [Abstract][Full Text] [Related]
7. Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP). Wutthiworawong B; Thitiratsanont U; Saovaprut C; Subhangkasen I; Geyuraphun B; Ampornprut A; Phumongkutchai J; Tephusdinnaayuthaya S J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S15-21. PubMed ID: 22043749 [TBL] [Abstract][Full Text] [Related]
8. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Kychenthal A; Dorta P Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity. Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449 [TBL] [Abstract][Full Text] [Related]
10. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin). Dorta P; Kychenthal A Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity. Erol N; Gürsoy H; Sahin A; Basmak H J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371 [TBL] [Abstract][Full Text] [Related]
13. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Honda S; Hirabayashi H; Tsukahara Y; Negi A Graefes Arch Clin Exp Ophthalmol; 2008 Jul; 246(7):1061-3. PubMed ID: 18320201 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity. Ekinci DY; Çelik K J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):54-60. PubMed ID: 31972042 [TBL] [Abstract][Full Text] [Related]
15. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. Geloneck MM; Chuang AZ; Clark WL; Hunt MG; Norman AA; Packwood EA; Tawansy KA; Mintz-Hittner HA; JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of bevacizumab for retinopathy of prematurity. Kuniyoshi K; Sugioka K; Sakuramoto H; Kusaka S; Wada N; Shimomura Y Jpn J Ophthalmol; 2014 May; 58(3):237-43. PubMed ID: 24566819 [TBL] [Abstract][Full Text] [Related]
17. Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP screening (ITCROPS) data base report number 7. Chhablani J; Rani PK; Balakrishnan D; Jalali S Semin Ophthalmol; 2014 Jul; 29(4):222-5. PubMed ID: 24117452 [TBL] [Abstract][Full Text] [Related]
18. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan. Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589 [TBL] [Abstract][Full Text] [Related]
19. Low dose versus conventional dose of intravitreal bevacizumab injection for retinopathy of prematurity: a case series with paired-eye comparison. Han J; Kim SE; Lee SC; Lee CS Acta Ophthalmol; 2018 Jun; 96(4):e475-e478. PubMed ID: 27011262 [TBL] [Abstract][Full Text] [Related]